title: Strategies for the treatment of intraocular inflammatory disease.
authors.affiliation: Laboratory of Immunology, National Eye Institute, NIH, Bethesda, Maryland, USA.
authors.forename: R B
authors.initials: RB
authors.lastname: Nussenblatt
authors.forename: R
authors.initials: R
authors.lastname: Schiffman
authors.forename: E
authors.initials: E
authors.lastname: Fortin
authors.forename: M
authors.initials: M
authors.lastname: Robinson
authors.forename: J
authors.initials: J
authors.lastname: Smith
authors.forename: L
authors.initials: L
authors.lastname: Rizzo
authors.forename: K
authors.initials: K
authors.lastname: Csaky
authors.forename: I
authors.initials: I
authors.lastname: Gery
authors.forename: T
authors.initials: T
authors.lastname: Waldmann
authors.forename: S M
authors.initials: SM
authors.lastname: Whitcup
mesh_terms: D000818:Animals; D019393:Arrestin / Q000627:therapeutic use; D016207:Cytokines / Q000096:biosynthesis / Q000235:genetics; D004195:Disease Models, Animal; D005136:Eye Proteins / Q000627:therapeutic use; D006801:Humans; D007108:Immune Tolerance; D007167:Immunotherapy / Q000379:methods; D051379:Mice; D012177:Retinol-Binding Proteins / Q000627:therapeutic use; D018418:Th2 Cells / Q000276:immunology; D014605:Uveitis / Q000276:immunology / Q000517:prevention & control / Q000628:therapy*; D000099214:Retinol-Binding Proteins, Interstitial
chemical_list: D019393:Arrestin; D016207:Cytokines; D005136:Eye Proteins; D012177:Retinol-Binding Proteins; D000099214:Retinol-Binding Proteins, Interstitial